Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Duncombe

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|November 3, 1988
Is circulating tumor necrosis factor bioactive?A S Duncombe, M K Brenner
Postgraduate Medical Journal|November 1, 1985
Spinal subarachnoid haemorrhage presenting as spinal block without meningismA S Duncombe, P G Kennedy
Neurology|June 1, 1985
Methysergide in progressive supranuclear palsyA S Duncombe, A J Lees
Lancet (London, England)|February 22, 1986
HTLV-III related illness and Christmas diseaseA S Duncombe, G F Savidge, J Craske
Clinical and Laboratory Haematology|January 1, 1986
Combination therapy of steroids and immunoglobulin in chronic refractory idiopathic thrombocytopenic purpura (ITP) enabling renal stone fragmentation by lithotripsyA S Duncombe, P J Kesteven, G F Savidge
British Journal of Haematology|January 1, 1987
Lupus-type coagulation inhibitor in hairy cell leukaemia and resolution with splenectomyA S Duncombe, R G Dalton, G F Savidge
Postgraduate Medical Journal|December 1, 1987
Compression of the optic chiasm due to a lymphoreticular malignancyR S Howard, A S Duncombe, C Owens, et al.
Lancet (London, England)|January 30, 1988
Bioactivity and immunoreactivity of tumour necrosis factor in cancer patientsA S Duncombe, D J Gottlieb, A Bianchi, et al.
Lancet (London, England)|May 21, 1998
Ototoxicity induced by once-daily gentamicinF El Bakri, A Pallett, A G Smith, et al.
British Journal of Haematology|June 1, 1987
C-reactive protein and cytosine arabinosideJ M Dudley, A S Duncombe, N G Slater, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|November 3, 1988
Is circulating tumor necrosis factor bioactive?A S Duncombe, M K Brenner
Postgraduate Medical Journal|November 1, 1985
Spinal subarachnoid haemorrhage presenting as spinal block without meningismA S Duncombe, P G Kennedy
Neurology|June 1, 1985
Methysergide in progressive supranuclear palsyA S Duncombe, A J Lees
Lancet (London, England)|February 22, 1986
HTLV-III related illness and Christmas diseaseA S Duncombe, G F Savidge, J Craske
Clinical and Laboratory Haematology|January 1, 1986
Combination therapy of steroids and immunoglobulin in chronic refractory idiopathic thrombocytopenic purpura (ITP) enabling renal stone fragmentation by lithotripsyA S Duncombe, P J Kesteven, G F Savidge
British Journal of Haematology|January 1, 1987
Lupus-type coagulation inhibitor in hairy cell leukaemia and resolution with splenectomyA S Duncombe, R G Dalton, G F Savidge
Postgraduate Medical Journal|December 1, 1987
Compression of the optic chiasm due to a lymphoreticular malignancyR S Howard, A S Duncombe, C Owens, et al.
Lancet (London, England)|January 30, 1988
Bioactivity and immunoreactivity of tumour necrosis factor in cancer patientsA S Duncombe, D J Gottlieb, A Bianchi, et al.
Lancet (London, England)|May 21, 1998
Ototoxicity induced by once-daily gentamicinF El Bakri, A Pallett, A G Smith, et al.
British Journal of Haematology|June 1, 1987
C-reactive protein and cytosine arabinosideJ M Dudley, A S Duncombe, N G Slater, et al.
Pageof 3